Announcements
Trials
Browse
Landscape
Clinical Trials
2 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
Bevacizumab
×
30 days
×
Clear all
Filters
3
NCT05239741
2026-04-17
MK-3475-C66
Merck Sharp & Dohme LLC
Phase 3
Recruiting
100 enrolled
NCT07216703
2026-04-17
TroFuse-036
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,023 enrolled